
CAS 1262618-39-2
:GS967
Description:
GS967 is a chemical compound that functions primarily as a selective inhibitor of the cardiac sodium channel NaV1.5, which plays a crucial role in cardiac action potentials and excitability. This compound is notable for its potential therapeutic applications in treating cardiac arrhythmias, particularly in conditions like long QT syndrome. GS967 exhibits a high degree of specificity for NaV1.5 over other sodium channels, which is essential for minimizing side effects associated with broader sodium channel inhibition. The compound is typically characterized by its molecular structure, which includes specific functional groups that contribute to its binding affinity and selectivity. Additionally, GS967 has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are critical for its efficacy and safety profile in clinical settings. As research continues, GS967 may provide insights into novel treatment strategies for various cardiac disorders, highlighting the importance of targeted pharmacological interventions in cardiology.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-
CAS:Formula:C14H7F6N3OPurity:99%Color and Shape:SolidMolecular weight:347.21536-(4-(Trifluoromethoxy)Phenyl)-3-(Trifluoromethyl)-[1,2,4]Triazolo[4,3-A]Pyridine
CAS:6-(4-(Trifluoromethoxy)Phenyl)-3-(Trifluoromethyl)-[1,2,4]Triazolo[4,3-A]PyridinePurity:98%Molecular weight:347.22g/molGS967
CAS:<p>GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).</p>Formula:C14H7F6N3OPurity:98% - >99.99%Color and Shape:SolidMolecular weight:347.22GS 967
CAS:<p>Inhibits cardiac late sodium channel current; antiarrhythmic</p>Formula:C14H7F6N3OPurity:Min. 95%Color and Shape:PowderMolecular weight:347.22 g/mol1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-
CAS:Purity:99%Molecular weight:347.2200012




